Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Pozycja w akcjach #84
Abbott Laboratories, together with its subsidiaries, discovers, develops,... Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Cena akcji
$101.91
Kapitalizacja rynkowa
$177.09B
Zmiana (1 dzień)
-1.97%
Zmiana (1 rok)
-19.78%
Kraj
US
Handel Abbott Laboratories (ABT)

Kategoria

Liczba akcji w obrocie dla Abbott Laboratories (ABT)
Liczba akcji w obrocie na dzień December 2025: 1.75B
Zgodnie z najnowszymi raportami finansowymi i ceną akcji Abbott Laboratories, aktualna liczba akcji w obrocie to 1.75B. Na koniec December 2024 firma posiadała 1.73B akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla Abbott Laboratories (ABT) od 2000 do 2026
Akcje w obrocie na koniec każdego roku
Rok Akcje w obrocie Zmień
2026 (TTM) 1.75B 0.00%
2025 1.75B 0.88%
2024 1.73B -0.14%
2023 1.73B -1.08%
2022 1.75B -1.24%
2021 1.78B 0.11%
2020 1.77B 0.28%
2019 1.77B 0.71%
2018 1.76B 0.69%
2017 1.74B 18.38%
2016 1.47B 0.01%
2015 1.47B -2.35%
2014 1.51B -2.59%
2013 1.55B -1.81%
2012 1.58B 0.40%
2011 1.57B 1.51%
2010 1.55B 0.03%
2009 1.55B 0.19%
2008 1.54B 0.03%
2007 1.54B 0.87%
2006 1.53B -1.46%
2005 1.55B -0.52%
2004 1.56B -0.14%
2003 1.56B 0.12%
2002 1.56B 0.68%
2001 1.55B 0.15%
2000 1.55B 0.00%
Akcje w obrocie dla podobnych firm lub konkurentów
Firma Akcje w obrocie Różnica Kraj
382.50M -78.11%
US
1.28B -26.58%
IE
1.28B -26.61%
IE
1.48B -15.13%
US
2.23B 27.85%
DE